08/10/2015 - 9:47am

In order to ensure that patients receive treatment for periodic paralysis, Taro will be partnering with Diplomat Pharmacy, where patients and caregivers will receive treatment access and support. 

08/10/2015 - 9:28am

According to the Substance Abuse Mental Health Services Administration, more than 24.5 million people age 12 or older in the U.S. (9.4% of the population) live with substance use disorders.

08/04/2015 - 12:43pm

More than 28% of those surveyed fill 20 or more prescriptions per year but only half of those know about prescription savings cards. 

08/04/2015 - 11:42am
The Food and Drug Administration has approved Aprecia Pharmaceuticals’ Spritam (levetiracetam), an epilepsy treatment that is the first FDA-approved drug that uses 3D printing technology. 
08/03/2015 - 3:34pm

The National Association of Boards of Pharmacy last week released a progress report urging state and federal regulation for the thousands of websites that illegally distribute medications.

07/31/2015 - 2:06pm

In late July, the Government Accountability Office released a report on how the lack of effective communications between the Drug Enforcement Agency and both pharmaceutical distributors and chain pharmacy headquarters has impacted legitimate access to pain medicines. "The agency’s report further validates the need for bipartisan, bicameral legislation," according to NACDS.

07/28/2015 - 6:26am

A GAO report released Monday suggests that the Drug Enforcement Agency should take steps to improve communications with pharmacists, manufacturers. 

07/27/2015 - 3:43pm

As the sole U.S. supplier of fluoxymesterone, Upsher-Smith sought a way to renew the product’s availability after the company’s initial API manufacturer discontinued its supply. 

07/27/2015 - 11:19am

The Food and Drug administration announced Friday that it had approved Praluent (alirocumab), a cholesterol-lowering PCSK9 inhibitor injection.